⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2191 | 1.00 | — | — | |
| SCHEMBL21114361 | 1.00 | GABRR1 (0.65) | — | |
| SCHEMBL456709 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL463250 | 0.97 | — | — | |
| Water SCHEMBL1565541 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL27603637 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL27599300 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL2582220 | 0.97 | — | — | |
| Ethylenediamine SCHEMBL8828910 | 0.94 | GABRR1 (0.67) | — | |
| Methylmalonic Acid SCHEMBL17223948 | 0.91 | GABRR1 (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260079167-A1 | BIOMEDICAL TEST FOR AUTISM | UNIV ARIZONA STATE (US) | 2026-03-19 | — | — | US | claimed |
| US-20250043352-A1 | Methods for Identifying a Companion Animal at Risk of Calcium Oxalate Stone Formation and Treatments and Compositions for Reducing the Risk | HILL'S PET NUTRITION, INC. (US) | 2025-02-06 | — | — | US | claimed |
| EP-4022089-B1 | METHODS FOR IDENTIFYING A COMPANION ANIMAL AT RISK OF CALCIUM OXALATE STONE FORMATION AND MEDICAL USES FOR REDUCING THE RISK | HILLS PET NUTRITION INC (US) | 2024-08-21 | — | — | EP | claimed |
| WO-2023235514-A1 | BIOMEDICAL TEST FOR AUTISM | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2023-12-07 | — | — | WO | claimed |
| EP-4022089-A1 | METHODS FOR IDENTIFYING A COMPANION ANIMAL AT RISK OF CALCIUM OXALATE STONE FORMATION AND TREATMENTS AND COMPOSITIONS FOR REDUCING THE RISK | Hill's Pet Nutrition, Inc. (US) | 2022-07-06 | — | — | EP | claimed |
| US-6372936-B1 | REACTING AMINO PROTECTED RACEMIC 3-AMINO-2-METHYL PROPIONIC ACID WITH ENANTIOMER OF CHIRAL AMINE TO FORM DIASTEREOMERIC SALTS, RECRYSTALLIZING SALTS FROM ETHYL ACETATE TO SEPARATE, RELEASING RESOLVED ACID WITH SOLUTION OF INORGANIC BASE | ELI LILLY AND COMPANY | 2002-04-16 | — | — | US | claimed |
| EP-1059286-A1 | Optical resolution of aminoisobutyric acid | ELI LILLY AND COMPANY (US) | 2000-12-13 | — | — | EP | claimed |
| US-20260079167-A1 | BIOMEDICAL TEST FOR AUTISM | UNIV ARIZONA STATE (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260008780-A1 | SUBSTITUTED 3,4-DIHYDROISOQUINOLIN-1(2H)-ONE DERIVATIVES AND RELATED USES | NODTHERA LTD (GB) | 2026-01-08 | — | — | US | disclosed |
| US-20250376709-A1 | PAPB AS A BIMOIETY-DEPENDENT THIOETHER INSTALLATION TOOL | UNIV UTAH RES FOUND (US) | 2025-12-11 | — | — | US | disclosed |
| US-12428427-B2 | Methods and compositions for targeting PD-L1 | ALIGOS THERAPEUTICS, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| EP-3899045-B1 | METHODS FOR IDENTIFYING A COMPANION ANIMAL SUSCEPTIBLE TO TREATMENT THAT REDUCES THE RISK OF STONE FORMATION AND USE OF COMPOSITIONS FOR REDUCING SUCH RISK | HILLS PET NUTRITION INC (US) | 2025-09-10 | — | — | EP | disclosed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | disclosed |
| US-5175181-A | Renin inhibitors, hypotensive agents | G. D. SEARLE & CO. (US) | 1992-12-29 | — | — | US | disclosed |
| US-5175170-A | Renin inhibitors, hypotensive agents | G. D. SEARLE & CO. (US) | 1992-12-29 | — | — | US | disclosed |
| US-5171751-A | Renin inhibitors, hypotensive agents | G. D. SEARLE & CO. (US) | 1992-12-15 | — | — | US | disclosed |
| US-5147888-A | Hypotensive agents; renin inhibitors | G. D. SEARLE & CO. (US) | 1992-09-15 | — | — | US | disclosed |
| EP-0117429-B1 | PHOSPHOROUS CONTAINING COMPOUNDS AS INHIBITORS OF ENKEPHALINASES | SCHERING CORPORATION (US) | 1987-09-02 | — | — | EP | disclosed |
| EP-0125208-A1 | Amino-lower-alkyl-penem derivatives, process for their preparation, pharmaceutical compositions containing them and their use | CIBA-GEIGY AG (CH) | 1984-11-14 | — | — | EP | disclosed |
| EP-0117429-A1 | Phosphorous containing compounds as inhibitors of enkephalinases | SCHERING CORPORATION (US) | 1984-09-05 | — | — | EP | disclosed |